journal article·2020-11Open access

Long Noncoding RNA HITTERS Protects Oral Squamous Cell Carcinoma Cells from Endoplasmic Reticulum Stress‐Induced Apoptosis via Promoting MRE11‐RAD50‐NBS1 Complex Formation

Chenzhou Wu, Wen Chen, Fanyuan Yu, Yihang Yuan, Yafei Chen, Douglas R. Hurst, Yi Li, Longjiang Li, Zhe Liu

Advanced Science· Volume 7· Issue 22

Abstract

Abstract Recent studies have proven that long noncoding RNAs (lncRNAs) exhibit regulatory functions of both DNA damage response (DDR) and endoplasmic reticulum (ER) stress. Herein, ER stress‐induced lncRNA transcriptomic changes are reported in human oral squamous cell carcinoma (OSCC) cells and a novel lncRNA HITTERS (H ERPUD1 intronic transcript of ER stress) is identified as the most significantly upregulated lncRNA. It is shown that HITTERS is a nucleus‐located lncRNA including two transcript variants. HITTERS lacks an independent promoter but shares the same promoter with HERPUD1. HITTERS is transcriptionally regulated by Activating Transcription Factor (ATF) 6, ATF4, X‐Box Binding Protein 1 (XBP1), and DNA methylation. In human OSCC tissues, HITTERS is significantly correlated with OSCC clinicopathological features and prognosis. Gain‐ and loss‐of‐function studies reveal that HITTERS promotes OSCC proliferation and invasion via influencing the expression of growth factor receptors and the downstream pathways. Once ER stress is triggered, HITTERS significantly attenuates ER stress‐induced apoptosis both in vivo and in vitro. Mechanically, HITTERS functions as RNA scaffold to promote MRE11‐RAD50‐NBS1 complex formation in the repair of ER stress‐induced DNA damage. To sum up, this study presents a novel lncRNA, namely HITTERS, which links ER stress and DDR together in OSCC.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer-related molecular mechanisms research · RNA modifications and cancer · RNA regulation and disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases and Department of Head and Neck Oncology West China Hospital of Stomatology Sichuan University Number 14, Unit 3, Renmin Nan Road Chengdu Sichuan 610041 China

State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases and Department of Endodontics West China Hospital of Stomatology Sichuan University Number 14, Unit 3, Renmin Nan Road Chengdu Sichuan 610041 China

Department of Pathology University of Alabama at Birmingham Birmingham AL 35294 USA

Funding

National Natural Science Foundation of China · Graduate Student's Research and Innovation Fund of Sichuan University

References (46)

Show source-provided references
1. 10.1016/j.ccr.2014.03.01510.1016/j.ccr.2014.03.015 ↗
2. 10.1038/nrc380010.1038/nrc3800 ↗
3. 10.1038/ncb318410.1038/ncb3184 ↗
4. 10.1126/science.120903810.1126/science.1209038 ↗
5. 10.1158/2159-8290.CD-18-152210.1158/2159-8290.CD-18-1522 ↗
6. 10.1038/s41571-019-0227-z10.1038/s41571-019-0227-z ↗
7. 10.1038/s41571-018-0114-z10.1038/s41571-018-0114-z ↗
8. 10.1186/s13059-017-1348-210.1186/s13059-017-1348-2 ↗
9. 10.1016/j.cell.2018.01.01110.1016/j.cell.2018.01.011 ↗
10. 10.1158/0008-5472.CAN-13-315910.1158/0008-5472.CAN-13-3159 ↗
11. 10.1158/1078-0432.CCR-18-077310.1158/1078-0432.CCR-18-0773 ↗
12. 10.1038/emboj.2013.22110.1038/emboj.2013.221 ↗
13. 10.1158/0008-5472.CAN-18-203410.1158/0008-5472.CAN-18-2034 ↗
14. 10.1038/s41556-018-0066-710.1038/s41556-018-0066-7 ↗
15. 10.1093/nar/gky119010.1093/nar/gky1190 ↗
16. 10.15252/embr.20154043710.15252/embr.201540437 ↗
17. 10.1152/ajpcell.00293.201610.1152/ajpcell.00293.2016 ↗
18. 10.1096/fj.201900643RRR10.1096/fj.201900643RRR ↗
19. 10.1089/ars.2017.727810.1089/ars.2017.7278 ↗
20. Liu H. · Eur. Rev. Med. Pharmacol. Sci. · 2019 · 23 · 5912
21. 10.1002/jcb.2798210.1002/jcb.27982 ↗
22. 10.1161/CIRCRESAHA.116.31053110.1161/CIRCRESAHA.116.310531 ↗
23. 10.1111/j.1365-2591.2006.01114.x10.1111/j.1365-2591.2006.01114.x ↗
24. 10.1111/jcpe.1239110.1111/jcpe.12391 ↗
25. 10.1016/j.yexcr.2006.09.00410.1016/j.yexcr.2006.09.004 ↗
26. 10.1074/jbc.M31372420010.1074/jbc.M313724200 ↗
27. 10.1126/science.112595110.1126/science.1125951 ↗
28. 10.1038/s41571-018-0113-010.1038/s41571-018-0113-0 ↗
29. 10.3390/ijms2011276710.3390/ijms20112767 ↗
30. 10.1146/annurev-biochem-062917-01241510.1146/annurev-biochem-062917-012415 ↗
31. 10.1038/ncomms1011210.1038/ncomms10112 ↗
32. 10.1158/2159-8290.CD-16-086010.1158/2159-8290.CD-16-0860 ↗
33. 10.1038/nrm304710.1038/nrm3047 ↗
34. 10.1016/j.cub.2008.03.04010.1016/j.cub.2008.03.040 ↗
35. 10.1016/j.dnarep.2010.10.00110.1016/j.dnarep.2010.10.001 ↗
36. 10.14735/amko20189510.14735/amko201895 ↗
37. 10.1038/onc.2017.18410.1038/onc.2017.184 ↗
38. Liu L. · Eur. Rev. Med. Pharmacol. Sci. · 2019 · 23 · 6194
39. 10.3233/CBM-17068310.3233/CBM-170683 ↗
40. 10.18632/oncotarget.1108710.18632/oncotarget.11087 ↗
41. 10.1158/0008-5472.CAN-18-321010.1158/0008-5472.CAN-18-3210 ↗
42. 10.1111/febs.1366010.1111/febs.13660 ↗
43. 10.1016/j.febslet.2013.08.03010.1016/j.febslet.2013.08.030 ↗
44. 10.1016/j.cell.2015.03.02510.1016/j.cell.2015.03.025 ↗
45. 10.1186/s12920-015-0159-010.1186/s12920-015-0159-0 ↗
46. 10.1002/advs.20190138010.1002/advs.201901380 ↗